Safety of baricitinib for the treatment of atopic dermatitis over a median of 1.6 years and up to 3.9 years of treatment: an updated integrated analysis of eight clinical trials.
The Journal of dermatological treatment
View this publicationThe Journal of dermatological treatment
View this publicationHematology (Amsterdam, Netherlands)
View this publicationThe Journal of dermatological treatment
View this publicationPublication categories: Top publication
Nature communications
View this publicationJournal of immunology (Baltimore, Md. : 1950)
View this publicationPsychopharmacology
View this publicationCell death discovery
View this publicationJournal of immunology (Baltimore, Md. : 1950)
View this publicationInfection
View this publicationbioRxiv : the preprint server for biology
View this publication